Lung Cancers Completed Phase 1 / 2 Trials for Irinotecan (DB00762)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00073866Combination Chemotherapy and Celecoxib in Treating Patients With Advanced Non-Small Cell Lung CancerTreatment